Skip to main content
OpenTrials

Clinical trial condition

Renal Cell Carcinoma (RCC)

Explore clinical trials studying Renal Cell Carcinoma (RCC). Study availability and eligibility vary by location and protocol.

53 public trials 22 recruiting studies
Refine in advanced search Browse all conditions

Renal Cell Carcinoma (RCC) trial results

Completed

Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors

NCT02646748

Conditions
Adenocarcinoma, Breast Cancer, Breast Diseases, +59 more
Locations
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • John Wayne Cancer Institute at Providence Saint John's Health Center Santa Monica, California, United States
  • Georgetown University Medical Center Lombardi CCC Washington D.C., District of Columbia, United States
  • Hematology-Oncology Associates of Treasure Coast Port Saint Lucie, Florida, United States
View all 17 locations
View Trial Details
Completed

Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers

NCT02178722

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +76 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • US Davis Cancer Center Sacramento, California, United States
  • University Of Colorado Cancer Center Aurora, Colorado, United States
View all 24 locations
View Trial Details
Completed

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

NCT01235962

Conditions
Adenocarcinoma, Cancer, Carcinoma, +15 more
Locations
  • Novartis Investigative Site Jonesboro, Arkansas, United States
  • Novartis Investigative Site Antioch, California, United States
  • Novartis Investigative Site Beverly Hills, California, United States
  • Novartis Investigative Site Fresno, California, United States
View all 312 locations
View Trial Details
Completed

A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies

NCT03538028

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +105 more
Locations
  • The Angeles Clinic and Research Center Los Angeles, California, United States
  • Hackensack Medical Center Hackensack, New Jersey, United States
  • Carolina BioOncology Institute Huntersville, North Carolina, United States
  • Vanderbilt University Medical Center Nashville, Tennessee, United States
View Trial Details
Completed

Phase 2 Study in Patients With MiT Tumors

NCT00557609

Conditions
Adenocarcinoma, Alveolar Soft Part Sarcoma (ASPS), Carcinoma, +22 more
Locations
  • San Francisco, California, United States
  • Santa Monica, California, United States
  • Miami, Florida, United States
  • Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers

NCT05891171

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Cancer, +64 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site Jacksonville, Florida, United States
  • Research Site Lake City, Florida, United States
  • Research Site Hinsdale, Illinois, United States
View all 14 locations
View Trial Details

Related conditions